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a  b  s  t  r  a  c  t
Mammalian  bone  has shown  a variety  of responses  to  2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD)  exposure  in  experimental  and  wildlife  studies.  Although  many  responses  have  been
well  characterized  in  the postcranial  skeleton,  dioxin-induced  effects  on  the cranium  are
largely unknown.  In  this  study,  we  investigated  the  effects  of  chronic  adult  exposure  to
TCDD on  cranial  size  and  shape  in  dioxin-resistant  Han/Wistar  (H/W)  and dioxin-sensitive
Long–Evans  (L–E)  rat  strains.  Three-dimensional  landmark  conﬁgurations  for  the  face,  vault,
and base  of the cranium  were  recorded  and  analyzed  using  geometric  morphometrics  (GM)
and  dose–response  modeling.  The  strongest  effects  were  shown  by  L–E  and  H/W  rats  with
daily  exposures  of 100  and  1000  ng  TCDD/kg  bw/day,  respectively,  resulting  in  signiﬁcant
reductions  in  centroid  size  (CS)  in  all three  cranial  modules  for both  strains  except  for  the
vault  in H/W  rats.  Consistent  with  previous  evidence  of  intraspeciﬁc  variation  in  TCDD
resistance,  the  benchmark  doses  (CEDs)  for cranial  size  reduction  in L–E  rats  were  roughly
10-fold lower  than  those  for H/W  rats.  For  both  strains,  the face  showed  the greatest  size
reduction from  the  highest  doses  of  TCDD  (i.e.,  3.6  and  6.3%  decreases  in  H/W  and  L–E
rats,  respectively),  most  likely  related  to dose-dependent  reductions  in limb  bone  size  and
body weight  gain.  However,  intrinsic  morphological  differences  between  strains  were  also
observed:  although  the control  groups  of H/W  and  L–E  rats  had  vaults  and  bases  of compa-
rable size,  the  face  was  6.4%  larger  in  L–E  rats.  Thus,  although  H/W  rats  possess  an  altered
aryl  hydrocarbon  receptor  (AhR)  that  appears  to mediate  and provides  some  resistance  to
TCDD  exposure,  their  smaller  reductions  in  facial  size  may  also  relate  to strain-speciﬁc  pat-
terns of  cranial  developm
how  ontogenetic  factors  
on the  mammalian  skelet
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. Introduction
Exposure to persistent organic pollutants (POPs) is a
ajor worldwide health concern. Although production of
ome POPs has been banned for decades, exposures can
till result from past uses, improper disposal practices, acci-
ents, and unregulated production in developing countries
1]. Once introduced into the environment, POPs degrade
lowly and undergo cycling and transport within the vari-
us compartments of the global ecosystem, where they can
e taken up and stored by species at all trophic levels of a
ood chain [2–4]. Understanding the toxicological mech-
nisms and potential adverse biological effects of these
hemicals is thus important for accurately assessing and
redicting human and animal health risks from exposure.
In general, POPs are associated with a wide range
f adverse biological effects, including immunotoxicity,
eurotoxicity, hepatoxicity, and tumor promotion [5]. As
ndocrine-disrupting compounds (EDCs), many of these
hemicals have also the ability to interfere with hormonal
rogramming and regulation of growth and development
n exposed organisms [6]. For POPs such as dioxins, a
ighly toxic group of chlorinated hydrocarbons, practically
ll adverse effects are mediated by the aryl hydrocarbon
eceptor (AhR). Among its many functions, the AhR appears
o play an essential role in the differentiation and mat-
ration of the osteoclasts and osteoblasts that form and
aintain bone [7], which can be disrupted when diox-
ns bind to the AhR protein [8]. The magnitude of toxic
otency of individual dioxin-like compounds is estimated
s a toxic equivalency factor (TEF) in relation to 2,3,7,8-
etrachlorodibenzo-p-dioxin (TCDD), the model compound
nd the most toxic member of the dioxin group [9].
Mammalian bone has shown a variety of responses to
CDD exposure in experimental and wildlife studies. In
he postcranial skeleton, TCDD exposure has been associ-
ted with signiﬁcant alterations in bone mineral density,
iomechanical strength, and bone geometry among differ-
nt rat strains and at dose levels of relevance to human and
ildlife exposure situations [10–13]. In the skull, dioxin-
nduced changes in the size and shape of the mandible of
xposed mice have been identiﬁed using geometric mor-
hometric techniques [14,15]. Teeth also exhibit dioxin
ensitivity, as low levels of in utero/lactational exposure
nd high levels of adult exposure have shown numerous
ffects on eruption, size, structure, and caries susceptibility
16–19]. However, with the exception of speciﬁc devel-
pmental defects such as cleft palate [20–23], the effects
f dioxins on cranial formation have not been extensively
tudied. It has been shown that a single dose of TCDD
an impair normal cranial growth in young adult male
an/Wistar rats [16], yet it is unclear how responses may
ary among different strains, exposure levels/periods, and
ranial traits or modules. Given that cranial form plays a
ey role in the protection and structural support for many
ital organs and sensory functions, in addition to its taxo-
omic, phylogenetic, and anthropological signiﬁcance, this
nformation has broad relevance across the life sciences.
In this study, we investigated the effects of chronic
CDD exposure on cranial size and shape in the adult
emale rats of two different strains, Han/Wistar (H/W) andorts 2 (2015) 472–481 473
Long–Evans (L–E). H/W rats are exceptionally resistant to
many endpoints of dioxin toxicity due to a truncated AhR
transactivation domain, while L–E rats express the wild-
type AhR [24,25]. In order to cover the whole spectrum of
biological effects observed in both strains [11–13,26], the
experimental treatments ranged from high to low (human
relevant) doses. Using geometric morphometrics (GM), the
crania of these rats were analyzed as three morphologi-
cal modules (i.e. face, vault, and base) that have previously
shown differential effects of growth reduction from envi-
ronmental stress in rats [27]. Building on previous work
showing cranial size reduction in rats resulting from early
adult exposure [16], this approach allowed us to identify
speciﬁc cranial traits and growth processes affected by
TCDD exposure, providing new information and a fuller
understanding about dioxin and dioxin-like effects on the
mammalian skeleton.
2. Materials and methods
2.1. Animals and treatments
The experimental protocol, including animal housing
and care, was approved by the Animal Experiment Commit-
tee at the University of Kuopio and the Kuopio Provincial
Government in Finland (for details, see [26]). Ten-week-
old female H/W (Kuopio) and L–E (Turku/AB) rats were
administered TCDD in corn oil by s.c. injection (2 ml/kg)
once per week for 20 weeks; control rats received corn
oil only. All rats were weighed weekly from birth until
week 25 [26] (Fig. 1). To achieve rapidly the kinetic steady
state, in order to mimic adult human steady-state expo-
sure, the ﬁrst treatment was a loading dose 5 times higher
than the 19 subsequent weekly maintenance doses [28].
The total doses were 0, 0.17, 1.7, 17 g (both strains) and
170 g (H/W only) TCDD/kg bw.  The daily doses were 0, 1,
10, 100, and 1000 ng TCDD/kg bw, respectively. Exposure
at the low dose, i.e. 1 ng TCDD/kg bw, resulted in animal
tissue levels comparable to the concentrations of poly-
chlorinated dibenzo-p-dioxins (PCDD) and dibenzofurans
(PCDF) observed in humans at background exposure levels
[12,26], which makes the applied dose levels and obtained
study results relevant to human health risk assessment.
2.2. Data collection
The heads from a total of 90 rats (10 per dose group)
were dissected and frozen before being skinned and then
skeletonized by dermestid beetles. On each of the skele-
tonized crania, the locations of 47 three-dimensional (3D)
landmarks were identiﬁed and marked by pencil (Table 1).
The number of selected landmarks was determined by the
size and complexity of the face (n = 23), vault (n = 8), and
base (n = 16) (Fig. 2). Numerous studies have shown that
the precision with which landmarks can be located varies
between different types of landmarks, such as those at
sutural intersections (Type 1), those at geometric max-
ima  of bony protrusions or depressions (Type 2), and those
at extreme locations with respect to other landmarks or
geometric entities (Type 3) [29]. For landmark measure-
ments on the skull, 3D digitizers have shown the highest
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Fig. 1. Body weight (g) of female Han/Wistar (H/W) and Long–Evans (L–E) rats in the study sample at 1 to 25 weeks of age. Lines are color-coded by strain
(Han/Wistar = red, Long–Evans = blue) and patterned by dose group (control = solid, 1 ng/kg bw/day =dash-dot, 10 ng/kg bw/day =long dashes, 100 ng/kg
bw/day =small dashes, and 1000 ng/kg bw/day =dots).
Table 1
Landmarks measured in this study.
Module Paired Landmark deﬁnition
Face x Anteriormost nasal–premaxilla intersection
x  Anteriormost point on maxilla
x Point of deepest lateral incurvature on the superior aspect of the infra-orbital ﬁssure
x  Frontal–premaxilla–maxilla intersection
x  Frontal–premaxilla–nasal intersection
Nasion (frontal–frontal–nasal–nasal intersection)
x Frontal–lacrimal–maxilla intersection
x  Anteriormost premaxilla–premaxilla intersection between the incisors
x  Inferiormost premaxilla–premaxilla intersection between the incisors
x  Anteriormost margin of incisive foramen
x  Point of deepest posterior incurvature on the inferior aspect of the infra-orbital ﬁssure
x  Posteriormost margin of incisive foramen
x  Lateral alveolar margin superior to second molar at the midpoint of anteroposterior length
Vault  x Medial point on the temporal line at the frontal–parietal intersection
Bregma (intersection at the coronal and sagittal sutures)
x  Point of deepest posterior incurvature on the anterior aspect of the squamosal bone
Lambda (parietal–parietal–interparietal intersection)
x  Medial point on the temporal line at the parietal–interparietal intersection, left
Base  Superiormost point on the posterior margin of the foramen magnum
x  Lateralmost point on the posterior margin of the foramen magnum
Anteriormost point on the inferior margin of the foramen magnum
x  Point of deepest posterior incurvature on the anterior aspect of the paraoccipital process
x  Lateralmost point on the perotic capsule
x  Occipital–auditory–sphenoid intersection
x  Anteriormost point on the inferior margin of the foramen ovale
al–ptery
latine–p
atine–pax  Lateral palat
Posterior pa
Anterior pal
precision for Type 1 landmarks and the lowest for Type 3
[30–33]. In order to minimize the potential for measure-
ment error, only Type 1 and Type 2 landmarks were used
in this study. With the cranium ﬁxed in a stable position,
the marked landmark locations were recorded digitally asgoid intersection
alatine intersection
latine intersection
3D coordinates with a Microscribe G2X system (Revware
Systems, Inc., 2009) by the same recorder in two trials on
different days. In the few cases where fractured or missing
bone did not permit landmark measurement, the specimen
was  omitted from the sample.
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odule (face = red, vault = blue, base = purple). Drawings are modiﬁed fro
.3. Geometric morphometrics (GM)
Complete landmark conﬁgurations from a total sam-
le of 83 crania were scaled, rotated, and translated by
eans of generalized least-squares Procrustes superimpo-
ition with MorphoJ version 1.06b software [34]. The initial
rocrustes ﬁt was performed on all conﬁgurations of all 47
andmarks for measurement error analysis, after an initial
heck for outliers. Following Jamniczky and Hallgrímsson
35], principal components analysis (PCA) and discriminant
unction analysis (DFA) were used to assess intra-observer
rror between the two trials. The PCA showed no differ-
nces in distribution (Fig. 3), and the DFA classiﬁed obser-
ations by measurement trial with relatively low accuracy
ig. 3. Principal components analysis (PCA) of intra-observer landmark measure
omponent of the Procrustes shape coordinates for all 47 landmarks in two mea
trial  1 = ﬁlled circle, trial 2 = hollow circle).ans (L–E) rats in the study sample. Landmarks are color-coded by cranial
radov and Argiropulo [57].
(63% with cross-validation). Both measurement trials were
averaged by individuals for all subsequent analyses.
To assess shape variation in the sample, PCA was  per-
formed on shape data resulting from a Procrustes ﬁt for the
entire set of 47 landmarks, combining all three cranial mod-
ules. As the majority of landmarks in the conﬁgurations
were paired (i.e., bilateral), only the symmetric compo-
nent of total shape variation (i.e., the averaged Procrustes
coordinates of each specimen and its mirrored image) was
analyzed (see [36]). This approach provided a graphical
display of shape changes in individual landmark conﬁg-
urations relative to the consensus shape, showing which
aspects of shape accounted for the greatest amount of
variation.
ment error. Score plot for the ﬁrst two PCs derived from the symmetric
surement trials for the study sample. Markers are symbol-coded by trial
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Fig. 4. Principal components analysis (PCA) of overall cranial shape variation in female Han/Wistar and Long–Evans rats in the study sample. Score plot
rustes s
(controlfor  the ﬁrst two  PCs derived from the symmetric component of the Proc
(Han/Wistar = red, Long–Evans = blue) and symbol-coded by dose group 
bw/day =triangle, and 1000 ng/kg bw/day =plus).
To assess size variation in the sample, Procrustes ﬁts
were performed separately on the three subsets of land-
marks for the face, vault, and base. The resulting dataset
from each Procrustes ﬁt included a standard size variable
of centroid size (CS), deﬁned as the square root of the sum of
squared distances of a set of landmarks from their centroid.
Data were evaluated with the Shapiro-Wilk test for nor-
mality and Levene’s test for homogeneity of variance, and
failed to meet parametric assumptions. Non-parametric
test statistics of Wilcoxon’s rank sum and Spearman’s rank
correlation coefﬁcient (rs) were thus used for comparisons
between the CS values and other measurements of postcra-
nial size and body weight for different dose groups and
strains. All CS analyses were performed with Stata version
10 statistical software (StataCorp LP 2007).
2.4. Dose–response modeling
A family of exponential models (PROAST version 38.9
[RIVM, Bilthoven, The Netherlands] in the R software
version 3.1.0, [R Development Core Team, R Foundation
for Statistical Computing, Vienna, Austria]) was used for
dose–response modeling of CS values of the face, base,
vault, and overall cranium. Based on the likelihood ratio
test, the appropriate model was ﬁtted to the data acquired
from each strain. The benchmark dose (critical effect dose,
CED) was calculated at a change of one standard deviation
of the response in unexposed subjects [37]. Furthermore,
CED at the lower bound of the associated 95% conﬁdence
interval (CED-L5) was computed as well as the CED/CED-L5
ratio [38].
3. ResultsOverall cranial shape variation in the sample is shown
by the PCA score plot in Fig. 4. More than one-third of the
total variation (i.e., 35%) is described by the ﬁrst princi-
pal component (PC 1), which shows a clear separation ofhape coordinates of all 47 landmarks. Markers are color-coded by strain
 = circle, 1 ng/kg bw/day =square, 10 ng/kg bw/day =diamond, 100 ng/kg
the H/W and L–E strains by negative and positive scores,
respectively. In Fig. 5, the shape changes that correspond
to a positive change in PC 1 score by 0.1 units are illus-
trated with a lollipop graph, which visualizes the location
and magnitude of these changes as lines extending from
the landmark locations in the consensus conﬁguration. As
indicated by the long lines in the face component, the most
extreme PC 1 shape changes were the anterior–posterior
displacement of landmarks around the nasal and maxil-
lary bones. By comparison, the maximum dimensions of
the vault and base modules were largely unchanged. These
results showed that L–E rats in general had larger and
longer faces than H/W rats relative to the rest of the cra-
nium. Within the L–E strain, the rats with the highest level
of TCDD exposure had the lowest PC 1 scores, indicating
reduced facial size in this group (Fig. 4). Among the H/W
rats, strong dose-related patterns in cranial shape were not
evident (Fig. 4).
Size variation in the sample is shown by differences in
CS values, which are reported as mean ± standard deviation
(SD) in Table 2 and as box plots in Fig. 6. Dose–response
relationships were found for all CS datasets according to
ANOVA and dose–response modeling, with the exception
of the H/W vault (Table 3). In L–E rats, all three cranial
modules were reduced (Table 2), i.e., face with a CED of
5.9 g/kg bw (maximal response of 6.4%), vault with a CED
of 0.0017 g/kg bw (maximal response of 1.9%), and base
with a CED of 6.7 g/kg bw (maximal response of 3.4%)
(Table 3). In H/W rats, CS values were reduced (Table 2)
for the face with a CED of 78 g/kg bw (maximal response
of 3.8%) and for the base with a CED of 73 g/kg bw
(maximal response of 3.2%) (Table 3). Due to these differ-
ences between H/W and L–E rats, CS values for the face
and the overall cranium showed a strong positive corre-
lation within each strain (rs = 0.90 and 0.95, p < 0.001) and
no correlation when the strains were combined (rs = 0.58,
p < 0.001) (Table 4). In contrast, base size was strongly pos-
itively correlated with overall cranial size both within and
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Fig. 5. Cranial shape changes associated with the major axis of variation (PC 1) in the principal components analysis (PCA) of female Han/Wistar and
Long–Evans rats in the study sample. Lollipop graph of the shape changes that correspond to a positive change in the PC 1 score by 0.1 units. The colored
circles  show the landmark locations on the consensus conﬁguration (face = red, vault = blue, base = purple) and the lines show the direction and magnitude
of  change in each landmark location.
Table 2
Mean and standard deviation (SD) values for centroid size (CS) values for the cranial modules of the face, vault, and base in female Han/Wistar and
Long–Evans rats following TCDD exposure.
Dose TCDD (ng/kw bw/day) Han/Wistar Long–Evans
Face Vault Base Face Vault Base
0 33.0 ± 0.6 22.4 ± 0.5 33.5 ± 0.5 35.1 ± 0.8 22.4 ± 0.2 33.7 ± 0.5
1  33.3 ± 1.0 22.8 ± 0.4 33.9 ± 0.6 35.2 ± 0.2 22.0 ± 0.2** 33.8 ± 0.4
10  32.9 ± 0.5 22.7 ± 0.3 33.6 ± 1.0 34.6 ± 0.4* 22.0 ± 0.2** 33.5 ± 0.2
100  32.8 ± 0.7 22.7 ± 0.4 33.8 ± 0.6 32.9 ± 0.4*** 22.0 ± 0.2** 32.6 ± 0.3***
1000 31.8 ± 0.4*** 22.4 ± 0.2 32.6 ± 0.3** n/a n/a n/a
* Statistically signiﬁcant difference from the control group at p < 0.05, Wilcoxon rank-sum test.
** Statistically signiﬁcant difference from the control group at p < 0.01, Wilcoxon rank-sum test.
*** Statistically signiﬁcant difference from the control group at p < 0.001, Wilcoxon rank-sum test.
Table 3
Results of benchmark dose modeling of centroid size (CS) values for the cranial modules of the face, vault, and base in female Han/Wistar and Long–Evans
rats  following TCDD exposure.
Dose TCDD (g/kg bw) Han/Wistar Long–Evans
Face Base Face Vault Base
CEDa 78.1 73.1 5.9 0 6.7
CED-L5b 59.2 53.5 5.1 0 5.6
CED/CED-L5c 1.3 1.4 1.2 1 1.2
Maximal Response (%)d 3.8 3.2 6.4 1.9 3.4
a Benchmark dose at a critical effect size (CES) of one standard deviation of the response in unexposed subjects.
b Lower bound of the conﬁdence interval of the estimated CED.
c Ratio of CED/CED-L5 as a measure for uncertainty (a maximum of 10 is acceptable).
d Difference from background as a percentage derived from the ﬁtted exponential model.
Table 4
Results of Spearman’s rank correlation test for the relationship between centroid sizes for the cranial modules (face, vault, and base) and the overall centroid
size  and bodyweight gain during TCDD treatment (weeks 10–25), and femur, tibia length, and cross-sectional area in female Han/Wistar and Long–Evans
rats.
Han/Wistar Long–Evans
Face Vault Base Face Vault Base
Overall centroid size 0.90*** 0.58*** 0.90*** 0.95*** 0.32*** 0.86***
Body weight gain 0.54*** 0.37* 0.56*** 0.80*** 0.33* 0.74***
Femur length 0.60*** 0.23 0.51*** 0.65*** 0.22 0.55***
Femur cross-sectional area 0.45** 0.17 0.49*** 0.45** 0.37* 0.39**
Tibia length 0.69*** 0.32* 0.67*** 0.42* −0.01 0.18
Tibia  cross-sectional area 0.60*** 0.37* 0.52*** 0.72*** 0.30 0.70***
* Statistically signiﬁcant at p < 0.05.
** Statistically signiﬁcant at p < 0.01.
*** Statistically signiﬁcant at p < 0.001.
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 and the
blue) anFig. 6. Box plots of centroid size (CS) values for the three cranial modules
sample. Boxes are color-coded by strain (Han/Wistar = red, Long–Evans = 
among strains (rs = 0.86–0.90, p < 0.001). Both face and base
CS values showed moderate to strong correlations with
measurements of body weight gain during TCDD exposure
(weeks 10–25) and posterior limb bone size (i.e., length
and cross-sectional area of the femur and tibia) recorded
in previous studies [11,26] (Table 4).
4. Discussion
This study demonstrates dose-dependent patterns of
decreasing cranial size in TCDD-exposed rats. Compared
to unexposed rats of the same strain, differences in CS
values reached levels of high signiﬁcance, suggesting that
some of the exposed rats did not achieve their full genetic
potential for cranial growth. In both strains, the greatest
size reductions occurred within the highest dose groups,
i.e., 1000 ng/kg bw/day in H/W rats and 100 ng/kg bw/day
in L–E rats, consistent with reductions in length, cross-
sectional area, and circumference of the femur, tibia, and
lumbar vertebrae observed at the same exposure levels in
other studies [11,12]. Furthermore, comparable to other
studies showing about 10-fold greater sensitivity in L–E
rats for decreased body weight [39] and reduced tibial
length [11], the dose–response models for the face and base
modules produced CED values that were about 10 times
lower for the L–E rats (Table 3). These modules showed sig-
niﬁcant positive correlations with femoral and tibial size
for both rat strains, and even stronger correlations with
body weight gain during TCDD treatment (Table 4). overall cranium in female Han/Wistar and Long–Evans rats in the study
d grouped by dose (0, 1, 10, 100, and 1000 ng/kg bw/day).
The cranial effects observed in the study sample reﬂect
allometric patterning in the mammalian skeleton, which
changes in proportions as it changes in size through-
out ontogeny [40]. Comparative studies of skull growth
in numerous different mammalian species have demon-
strated that the vault follows a neural pattern of growth
related to the expansion of the brain and the facial skele-
ton follows the somatic pattern of the postcranial skeleton,
both of which are accommodated by an intermediate zone
formed by the cranial base ([41]: 283). It is therefore not
surprising that in this study the face shows the strongest
correlations with limb bone size and the vault shows the
weakest (Table 4). Taken together, these results suggest
that the size reductions exhibited by the different cra-
nial components of the TCDD-exposed rats may  be caused
by the systemic disruption of formative growth in the
adult skeleton, rather than by actions speciﬁc or exclusive
to the cranium. These ﬁndings are consistent with those
reported in a previous experiment, where young adult H/W
rats (i.e., 11–12 weeks old) were given a single dose of
1000 g TCDD/kg and 6 weeks later showed different cra-
nial proportions and lower body weight than the controls,
in addition to perturbed tooth formation [16]. Concurrent
decreases in head and body dimensions have also been
observed in cortisone-treated male rats [42] and human
infants exposed to AhR ligands such as polycyclic aromatic
hydrocarbons (PAHs) [43] also see [58].Among the three cranial modules analyzed, the facial
skeleton exhibited the greatest magnitude size decrease in
TCDD-exposed rats. Between the control and highest dose
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roups, mean CS values for the face showed 3.6 and 6.3%
ecreases in H/W and L–E rats, compared to 2.7 and 3.2%
ecreases for the base, respectively (Table 2). These results
emonstrate the importance of the timing of exposure as
 factor in TCDD toxicity. Although the skeleton grows
hroughout life in most vertebrates, as new bone is added
nd old bone is removed in a continuous process of remod-
ling, the rates of growth related to adult bone formation
hange signiﬁcantly across a short period of time. For the
aboratory rat, whose average lifespan is 3 years, these
hanges occur within several weeks or months after birth
44]. In the neural growth pattern of the mammalian cranial
ault, there is a rapid phase of enlargement in prenatal and
arly postnatal life and then relatively precious termina-
ion of growth in width before anteroposterior length [41].
lthough the vault of the rat attains 93% of its adult size
uring the ﬁrst month of life, the face exhibits signiﬁcant
rowth until 5 months of age [45], speciﬁcally in the upper
acial skeleton associated with the respiratory and alimen-
ary tracts ([41]: 298). Thus, as rats and other mammals
ge, their faces become relatively elongated with respect to
he cranial base and braincase ([46]: 1165). Moreover, the
ace of the young rat grows faster than the neurocranium,
hich it normally surpasses in anteroposterior length in
emale L–E rats at 60 days of age [47]. The stunted faces of
hese rats therefore can be attributed to the fact that expo-
ure lasted for the entire period when the face becomes
ncreasingly dominant in total skull length, i.e., from the
econd to the seventh months of life [47].
The mechanisms of growth by which cranial propor-
ions change are essentially the same as those throughout
he mammalian skeleton, and these processes can be
ltered or disrupted by a variety of internal and exter-
al forces [41]. Similar to our results, differential growth
ffects among the face, vault, and base have been observed
n crania of rats that were malnourished during differ-
nt ontogenetic periods [27]. Those malnourished during
arly development (i.e., from birth to weaning) showed
he greatest size reduction in the vault, and when starva-
ion continued until adulthood, the greatest size reduction
as observed in the face [27]. In this study, it is therefore
ossible that decreased food consumption, as reﬂected in
he dose-dependent decreases in body weight gain by the
xposed rats, is the proximate cause of the observed cranial
ffects. Loss of body weight from hypophagia is a character-
stic symptom of TCDD intoxication and appears to be the
rimary mechanism of TCDD lethality [48]. However, when
CDD-treated rats have been subjected to total parenteral
utrition, leading to an equal gain in body weight with con-
rol rats, no alleviating effect on TCDD lethality has been
bserved [49,50]. There thus appear to be numerous mech-
nisms of TCDD lethality, in addition to many sublethal and
ossibly inter-related mechanisms of TCDD toxicity, which
emain to be fully understood [48].
Interspeciﬁc and intraspeciﬁc difference have been
bserved in rodent skeletal development with respect to
he sequence of ossiﬁcation [51], yet most comparisons
f H/W and L–E strains have focused exclusively on their
nown genetic differences. In H/W rats, two point muta-
ions in the gene for the AhR protein appear to provide the
ighest TCDD resistance of any laboratory animal [24,48].orts 2 (2015) 472–481 479
However, as shown in this study, there are also intrin-
sic phenotypic differences in the skeletons of these two
strains. Although the skulls of the control groups of H/W
and L–E rats have cranial vaults and bases of comparable
size, the face is 6.4% larger in L–E rats (Table 2, Fig. 5). This
difference was  relatively unaffected by low and medium
TCDD exposure (resulting in 5.7 and 5.2% larger faces in
L–E rats, respectively), but dropped close to unity at the
highest exposure level for L–E rats (Table 2, Fig. 5). This
change was  due to a signiﬁcant decrease in L–E face size
(mean decrease = 1.7 mm,  p < 0.001) without any signiﬁ-
cant decrease in H/W face size (Table 3, Fig. 6). At the
highest exposure level for H/W rats, where TCDD doses
were 10-fold greater than the highest exposure level for
L–E rats, facial reduction was signiﬁcant but less dramatic
(mean decrease = 1.0 mm,  p < 0.001).
The smaller decrease in H/W facial size is consistent
with previous observations of H/W resistance to TCDD in
numerous other endpoints. Nonetheless, it is well known
that the impact of the altered AhR in H/W rats is endpoint-
dependent, due to various combinations of downstream
molecular pathways and biochemical processes [52]. Thus,
the present results could also reﬂect lower growth poten-
tial in the H/W face related to its naturally smaller size. If
L–E rats have a longer and/or later period of facial growth by
comparison, during adulthood their faces may  remain more
susceptible to environmental stressors [53–55], which can
alter natural between-strain differences in cranial shape
[56]. Furthermore, although the H/W and L–E rats have dif-
ferent AhR alleles, ﬁve inbred strains of mice that possess
the same AhR alleles have shown different TCDD-induced
changes in mandibular size and shape [15]. These ﬁndings
suggest that between-strain differences in TCDD responses
may  involve genes beyond the AhR locus, such as those
that control the genetic architecture of a particular trait
[15]. Consistent with these ﬁndings, our results suggest
that genetically programmed differences in growth poten-
tial may  modulate TCDD toxicity in different rat stains.
Further research on H/W and L–E rats with in utero and
lactational exposure to TCDD will help to clarify the role of
these various factors of dioxin toxicity in the skull.
5. Conclusions
In this study, we  show patterns of altered cranial form
in H/W and L–E strains of female rats following long-term
adult exposure to TCDD. Dose–response modeling of size
variables for three cranial modules (face, vault, and base)
produced considerably lower benchmark doses for the L–E
rats, consistent with previous studies showing dioxin sen-
sitivity by L–E rats in numerous aspects of somatic growth.
The observed cranial patterns have signiﬁcant correlations
with TCDD-induced decreases in limb bone size and body
weight gain, suggesting malnutrition as a proximate cause
of these effects through the systematic disruption of adult
skeletal formation. For both rat strains, the face showed
greatest alterations by high doses of TCDD during the expo-
sure period, when this part of the cranium is least mature
and most sensitive to environmental stressors. However,
the face was also the only cranial module that showed
intrinsic size differences between these two  rat strains.
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Although H/W rats possess an altered AhR that appears
to confer high dioxin resistance in a variety of endpoints,
it is possible that the observed differences in facial reduc-
tion also reﬂect natural variation in allometry and ontogeny
between H/W and L-E rats.
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